MYCN and Ewing sarcoma: These types of variants are not generally detected with commercial amplicon-based NGS panels, despite being of critical importance for the clinical management and diagnosis of paediatric patients (e.g. MYCN amplification in neuroblastoma, EWSR1 in Ewing’s sarcoma).